Differences in the potency of ACAT inhibitors in two assay systems.
Harte
R A
RA
Department of Biochemistry and Genetics, Medical School, The University, Newcastle Upon Tyne, U.K.
Jackson
B
B
Suckling
K E
KE
Yeaman
S J
SJ
D000214:Acyl Coenzyme A / Q000378:metabolism; D000813:Anilides / Q000494:pharmacology; D000818:Animals; D002250:Carbon Radioisotopes; D007093:Imidazoles / Q000494:pharmacology; D007202:Indicators and Reagents; D007700:Kinetics; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology*; D011865:Radioisotope Dilution Technique; D051381:Rats; D017207:Rats, Sprague-Dawley; D002785:Sterol O-Acyltransferase / Q000032:analysis* / Q000037:antagonists & inhibitors / Q000378:metabolism*; D014508:Urea / Q000031:analogs & derivatives / Q000494:pharmacology
D000214:Acyl Coenzyme A; D000813:Anilides; D002250:Carbon Radioisotopes; D007093:Imidazoles; D007202:Indicators and Reagents; C069304:PD 128042; C017585:oleoyl-coenzyme A; D014508:Urea; C084073:lecimibide; D002785:Sterol O-Acyltransferase; C054659:octimibate